Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Gains from Investment Securities (2023 - 2025)

Onconetix (ONCO) has disclosed Gains from Investment Securities for 2 consecutive years, with $16668.0 as the latest value for Q3 2024.

  • On a quarterly basis, Gains from Investment Securities fell 76.47% to $16668.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $16668.0, a 76.47% decrease, with the full-year FY2024 number at $87864.0, up 84.51% from a year prior.
  • Gains from Investment Securities was $16668.0 for Q3 2024 at Onconetix, up from $3125.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $512940.0 in Q2 2023 to a low of -$23117.0 in Q1 2023.